BioCryst Pharmaceuticals Inc (NASDAQ: BCRX)
ALERT – STOCK RATING UPGRADE
Stock Rating Upgrade
Of late the Value Trend Rating for BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) improved from D to C reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) stock closed at $7.16 on 8/31/18 after being unchanged was unchanged. However, this flat performance was accompanied by exceptionally low trading volume at 49% of normal. The stock has declined -0.8% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
BCRX’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
BCRX has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. BCRX has a very high Power Rating of 86 but a very low Appreciation Score of 6, producing the Low Neutral Value Trend Rating.